 |
Corporate News
05-Feb-24
|
|
|
|
|
|
|
|
|
|
|
|
J B Chemicals & Pharmaceuticals allots 1.07 lakh equity shares under ESOP
|
|
|
|
|
|
|
|
J B Chemicals & Pharmaceuticals has allotted 107,190 equity shares under ESOP on 05 February 2024. Consequently, the issued, subscribed and paid up capital has increased from 15,50,44,160 equity shares of Re. 1 each to 15,51,51,350 equity shares of Re. 1 each.
|
|
|
|
Previous News |
J B Chemicals & Pharmaceuticals Ltd up for fifth session
(
Hot Pursuit
-
13-Jun-24
13:00
)
|
|
|
J B Chemicals & Pharmaceuticals consolidated net profit rises 35.50% in the June 2023 quarter
(
Results
-
Announcements
09-Aug-23
17:30
)
|
|
|
J B Chemicals & Pharmaceuticals consolidated net profit rises 13.64% in the September 2022 quarter
(
Results
-
Announcements
12-Nov-22
08:16
)
|
|
|
J B Chemicals & Pharmaceuticals completes acquisition of brand Azmarda from Novartis
(
Corporate News
-
12-Apr-22
21:19
)
|
|
|
J B Chemicals & Pharmaceuticals to pay interim dividend of Rs 8.50
(
Market Beat
-
Reports
10-Feb-21
19:36
)
|
|
|
J B Chemicals & Pharmaceuticals to discuss results
(
Corporate News
-
27-Jul-22
11:54
)
|
|
|
J B Chemicals & Pharmaceuticals consolidated net profit rises 82.39% in the September 2019 quarter
(
Results
-
Announcements
12-Nov-19
17:38
)
|
|
|
J B Pharma hits record high after Q3 PAT climbs 26% YoY
(
Hot Pursuit
-
07-Feb-24
15:53
)
|
|
|
JB Pharma to acquire Razel franchise from Glenmark Pharma for Rs 314 cr
(
Hot Pursuit
-
15-Dec-22
11:36
)
|
|
|
J B Chemicals & Pharmaceuticals standalone net profit declines 47.66% in the March 2018 quarter
(
Results
-
Announcements
26-May-18
15:02
)
|
|
|
J B Chemicals & Pharmaceuticals allots 10,210 equity shares under ESOS
(
Corporate News
-
30-Nov-23
10:34
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|